Hi,
Cipla's Desirox is economical, no doubt about that. But, the company hasn't performed any trials of the drug like Novartis had for Exjade. It may be the same drug like Exjade but then trials are important too. I would still prefer Exjade. Its the same cost as desferal here in India. So, desferal was affordable to those who were on it, then they should choose Exjade and not Desirox.
Ciplas's Kelfer did give problems to majority of the thals. Joint pains, drop in counts were the common ones. Trials were done for kelfer, hence the side-effects were known. We know Exjade's side-effects but not Desirox's.
\peace/